Iraq Seeks 6 Million Bpd OPEC+ Oil Quota 
Gold Prices Rebound as Dollar Weakens, Fed Decision Looms 
Asian Currencies Steady as Yen Holds Firm, Oil Tops $100 
U.S. Stock Futures Steady as Oil Tops $100 Ahead of Inflation Data 
Asian Stocks Fall as Oil Tops $100, Yields Rise 
German Inflation Accelerates to 2.9% in August 
Canada Retaliatory Tariffs on U.S. Goods Take Effect 
Gold Prices Rise as Yen Rally Weakens Dollar 
Iran Threatens Gulf Energy Assets as U.S. Tensions Escalate 
Asian Stocks Mixed as AI Chip Rally Meets Oil Surge 
Oil Prices Climb as Iran Threatens Gulf Energy Infrastructure 
UK Food Inflation Forecast to Hit 6.4% by Mid-2027 
Norway Core Inflation Rises to 3% in August 
Brent Oil Tops $100 as Middle East Conflict Threatens Supply 
Fitch Eyes Japan Budget for Fiscal Discipline 
ECB Rate Hike in Focus as Oil Tops $100 
Hormuz Shipping Slows as Iran Threats Lift Oil Risks 
Add as a preferred source on Google
Eli Lilly to Introduce Mounjaro Weight-Loss Drug in Hong Kong by Year-End
Global pharmaceutical giant Eli Lilly is gearing up to launch its weight-loss drug, Mounjaro, in Hong Kong by the end of this year. According to a report from Bloomberg News, the company has received approval from Hong Kong's government to sell its tirzepatide injections under the Mounjaro brand.
Mounjaro for Weight Management and Diabetes
Eli Lilly's Mounjaro is designed for both long-term weight management and the treatment of type 2 diabetes. It will be available on the Kwikpen device, which allows for easy self-administration. The company aims to address the growing demand for effective weight-loss treatments while continuing to provide solutions for diabetes management.
Hong Kong Market Entry
Hong Kong marks a strategic entry point for Eli Lilly as it expands its global presence. With the approval of Mounjaro, the company is poised to offer a highly anticipated solution for individuals struggling with obesity and related health issues. The weight-loss sector has seen significant growth in recent years, and Mounjaro is expected to make a notable impact.
